The constitutive activation of NF-kB in various types of solid tumors and hematological cancers, such as Hodgkin lymphoma (HL) and multiple myeloma, has been previously described [16, 17]. Here, NFKB1 is linked to hematopoietic and lymphoid cell neoplasm.